MRK Stock Summary and Trading Ideas (Merck Common (New) | NYSE:MRK)

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).

What symbol and exchange does Merck Common (New) shares trade?

Merck Common (New) trades on the NYSE stock market under the symbol MRK.

What is Merck Common (New) stock price doing today?

As of June 12, 2026, MRK stock price declined to $119.05 with 8,721,935 million shares trading.

What is Merck Common (New)'s Beta?

MRK has a beta of 0.47, meaning it tends to be less sensitive to market movements. MRK has a correlation of 0.04 to the broad based SPY ETF.

How much is Merck Common (New) worth?

MRK has a market cap of $294.03 billion. This is considered a Mega Cap stock.

How much money does Merck Common (New) make?

Last quarter Merck Common (New) reported $16 billion in Revenue and -$1.28 earnings per share. This beat revenue expectation by $429 million and exceeded earnings estimates by $.20.

What is the highest and lowest price Merck Common (New) traded in the last 3 year period?

In the last 3 years, MRK traded as high as $134.63 and as low as $73.31.

What are the top ETFs holding Merck Common (New)?

The top ETF exchange traded funds that MRK belongs to (by Net Assets): VTI, VOO, SCHD, IVV, SPY.

Is Merck Common (New) (MRK) a good investment?

MRK has outperformed the market in the last year with a price return of +49.6% while the SPY ETF gained +24.1%. However, in the short term, MRK had mixed performance relative to the market. It has underperformed in the last 3 months, returning +3.4% vs +11.6% return in SPY. But in the last 2 weeks, MRK shares have fared better than the market returning +0.3% compared to SPY -1.9%.

What are the support and resistance levels for Merck Common (New) (MRK)?

MRK support price is $118.41 and resistance is $123.11 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MRK shares will trade within this expected range on the day.